Results 271 to 280 of about 19,002,199 (367)

Human plasma lipoproteins regulate apolipoprotein E secretion from a post-Golgi compartment.

open access: hybrid, 1992
S.Q. Ye   +3 more
openalex   +1 more source

Comparative Proteomics of Salinity Stress Responses in Fish and Aquatic Invertebrates

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Fluctuating salinity is symptomatic of climate change challenging aquatic species. The melting of polar ice, rising sea levels, coastal surface and groundwater salinization, and increased evaporation in arid habitats alter salinity worldwide. Moreover, the frequency and intensity of extreme weather events such as rainstorms and floods increase,
Maxime Leprêtre   +3 more
wiley   +1 more source

Inherited Dyslipidemic Splenomegaly: A Genetic Macrophage Storage Disorder Caused by Disruptive Apolipoprotein E (<i>APOE</i>) Variants. [PDF]

open access: yesGenes (Basel)
Ferreira EA   +7 more
europepmc   +1 more source

Proteomic Insight Into Alzheimer's Disease Pathogenesis Pathways

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Alzheimer's disease (AD) is a leading cause of dementia, but the pathogenesis mechanism is still elusive. Advances in proteomics have uncovered key molecular mechanisms underlying AD, revealing a complex network of dysregulated pathways, including amyloid metabolism, tau pathology, apolipoprotein E (APOE), protein degradation ...
Taekyung Ryu   +3 more
wiley   +1 more source

Gene polymorphisms of CETP and apolipoprotein E in elderly subjects with cognitive impairment

open access: yesOpen Life Sciences, 2012
Niculescu Loredan   +3 more
doaj   +1 more source

Is Alzheimer's disease an apolipoprotein E amyloidosis?

open access: hybrid, 1995
Thomas Wısnıewskı   +4 more
openalex   +1 more source

Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients

open access: yesPROTEOMICS – Clinical Applications, EarlyView.
ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy